Garcinol's antiobesity potential

摘要

Garcinol-containing compositions for the therapeutic management of obesity are disclosed. More specifically, the invention relates to the use of garcinol for a) maintaining energy balance in a mammalian adipocyte system, b) managing hypercholesterolemia, and c) reducing weight gain in mammals. Regarding Also disclosed is the modification of the gut microbiota and the increase of the beneficial microbial Ackermansia muciniphila by garcinol. [Selection diagram] Fig. 1b